vs

Side-by-side financial comparison of Amer Sports, Inc. (AS) and Organon & Co. (OGN). Click either name above to swap in a different company.

Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× Amer Sports, Inc.). Amer Sports, Inc. runs the higher net margin — 1.8% vs -13.6%, a 15.4% gap on every dollar of revenue. Organon & Co. produced more free cash flow last quarter ($96.0M vs $92.2M).

Amer Sports, Inc. is a Finnish multinational sporting equipment division based in Helsinki, Finland. Established in 1950 as an industrial conglomerate with interests as diverse as tobacco trading, ship owning and publishing, Amer has gradually evolved into a multinational firm devoted to the production and marketing of sporting goods. The company employs over 9,700 people. Since 2018, Amer has been a subsidiary of Chinese retail conglomerate Anta Sports.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

AS vs OGN — Head-to-Head

Bigger by revenue
OGN
OGN
1.4× larger
OGN
$1.5B
$1.1B
AS
Higher net margin
AS
AS
15.4% more per $
AS
1.8%
-13.6%
OGN
More free cash flow
OGN
OGN
$3.8M more FCF
OGN
$96.0M
$92.2M
AS

Income Statement — Q1 FY2024 vs Q4 FY2025

Metric
AS
AS
OGN
OGN
Revenue
$1.1B
$1.5B
Net Profit
$19.0M
$-205.0M
Gross Margin
52.8%
49.2%
Operating Margin
12.4%
-9.8%
Net Margin
1.8%
-13.6%
Revenue YoY
-5.3%
Net Profit YoY
-288.1%
EPS (diluted)
$0.05
$-0.78

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AS
AS
OGN
OGN
Q4 25
$1.5B
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
$1.6B
Q2 24
$1.6B
Q1 24
$1.1B
$1.6B
Net Profit
AS
AS
OGN
OGN
Q4 25
$-205.0M
Q3 25
$160.0M
Q2 25
$145.0M
Q1 25
$87.0M
Q4 24
$109.0M
Q3 24
$359.0M
Q2 24
$195.0M
Q1 24
$19.0M
$201.0M
Gross Margin
AS
AS
OGN
OGN
Q4 25
49.2%
Q3 25
53.5%
Q2 25
54.8%
Q1 25
55.6%
Q4 24
56.3%
Q3 24
58.3%
Q2 24
58.4%
Q1 24
52.8%
59.0%
Operating Margin
AS
AS
OGN
OGN
Q4 25
-9.8%
Q3 25
15.2%
Q2 25
14.4%
Q1 25
6.7%
Q4 24
8.1%
Q3 24
13.1%
Q2 24
14.6%
Q1 24
12.4%
14.5%
Net Margin
AS
AS
OGN
OGN
Q4 25
-13.6%
Q3 25
10.0%
Q2 25
9.1%
Q1 25
5.8%
Q4 24
6.8%
Q3 24
22.7%
Q2 24
12.1%
Q1 24
1.8%
12.4%
EPS (diluted)
AS
AS
OGN
OGN
Q4 25
$-0.78
Q3 25
$0.61
Q2 25
$0.56
Q1 25
$0.33
Q4 24
$0.42
Q3 24
$1.38
Q2 24
$0.75
Q1 24
$0.05
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AS
AS
OGN
OGN
Cash + ST InvestmentsLiquidity on hand
$574.0M
Total DebtLower is stronger
$8.6B
Stockholders' EquityBook value
$752.0M
Total Assets
$12.9B
Debt / EquityLower = less leverage
11.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AS
AS
OGN
OGN
Q4 25
$574.0M
Q3 25
$672.0M
Q2 25
$599.0M
Q1 25
$547.0M
Q4 24
$675.0M
Q3 24
$763.0M
Q2 24
$704.0M
Q1 24
$575.0M
Total Debt
AS
AS
OGN
OGN
Q4 25
$8.6B
Q3 25
$8.8B
Q2 25
$8.9B
Q1 25
$9.0B
Q4 24
$8.9B
Q3 24
$8.7B
Q2 24
$8.7B
Q1 24
$8.7B
Stockholders' Equity
AS
AS
OGN
OGN
Q4 25
$752.0M
Q3 25
$906.0M
Q2 25
$733.0M
Q1 25
$542.0M
Q4 24
$472.0M
Q3 24
$493.0M
Q2 24
$144.0M
Q1 24
$48.0M
Total Assets
AS
AS
OGN
OGN
Q4 25
$12.9B
Q3 25
$13.6B
Q2 25
$13.5B
Q1 25
$13.2B
Q4 24
$13.1B
Q3 24
$12.8B
Q2 24
$12.2B
Q1 24
$11.9B
Debt / Equity
AS
AS
OGN
OGN
Q4 25
11.49×
Q3 25
9.74×
Q2 25
12.14×
Q1 25
16.52×
Q4 24
18.81×
Q3 24
17.75×
Q2 24
60.11×
Q1 24
181.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AS
AS
OGN
OGN
Operating Cash FlowLast quarter
$114.3M
$141.0M
Free Cash FlowOCF − Capex
$92.2M
$96.0M
FCF MarginFCF / Revenue
8.8%
6.4%
Capex IntensityCapex / Revenue
2.1%
3.0%
Cash ConversionOCF / Net Profit
6.02×
TTM Free Cash FlowTrailing 4 quarters
$538.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AS
AS
OGN
OGN
Q4 25
$141.0M
Q3 25
$264.0M
Q2 25
$220.0M
Q1 25
$75.0M
Q4 24
$390.0M
Q3 24
$141.0M
Q2 24
$332.0M
Q1 24
$114.3M
$76.0M
Free Cash Flow
AS
AS
OGN
OGN
Q4 25
$96.0M
Q3 25
$218.0M
Q2 25
$181.0M
Q1 25
$43.0M
Q4 24
$335.0M
Q3 24
$99.0M
Q2 24
$300.0M
Q1 24
$92.2M
$30.0M
FCF Margin
AS
AS
OGN
OGN
Q4 25
6.4%
Q3 25
13.6%
Q2 25
11.4%
Q1 25
2.8%
Q4 24
21.0%
Q3 24
6.3%
Q2 24
18.7%
Q1 24
8.8%
1.8%
Capex Intensity
AS
AS
OGN
OGN
Q4 25
3.0%
Q3 25
2.9%
Q2 25
2.4%
Q1 25
2.1%
Q4 24
3.5%
Q3 24
2.7%
Q2 24
2.0%
Q1 24
2.1%
2.8%
Cash Conversion
AS
AS
OGN
OGN
Q4 25
Q3 25
1.65×
Q2 25
1.52×
Q1 25
0.86×
Q4 24
3.58×
Q3 24
0.39×
Q2 24
1.70×
Q1 24
6.02×
0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AS
AS

Americas2$409.6M39%
EMEA1$356.9M34%
Greater China3$205.6M20%
Asia Pacific4$78.2M7%

OGN
OGN

Segment breakdown not available.

Related Comparisons